Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-3298

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70518-3298). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of Atorvastatin Calcium with NDC code 70518-3208-00, manufactured by Novadoz Pharmaceuticals LLC. It comes in tablet form with 10mg strength and a quantity of 30. The lot number and source NDC are provided, along with storage instructions stating it should be kept between 20-26°C (63-77°F) with excursions permitted to 15-30°C (59-86°F). It is advised to keep this medication away from children. Directions for use are found in the package insert. This medication has been repackaged by RemedyRepack Inc. and is for RX use only.*

FDA Label Image

Figure-01 (Atorvastatin Figure 01)

FDA Label Image

Figure-02 (Atorvastatin Figure 02)

The text appears to be a graph showing the cumulative hazard percentage, with data points labeled as "1517" and "10 7". It also includes a hazard ratio with confidence interval and p-value. The graph displays the time to the first primary endpoint through four years of follow-up. No additional information is available to provide further context or explanation of the data.*

FDA Label Image

Figure-03 (Atorvastatin Figure 03)

This is a clinical trial result for the use of Atorvastatin at doses of 10mg and 80mg in decreasing the risk of major cardiovascular events in a group of subjects. The numbers represent the percentages of subjects experiencing such events at different time points. Atorvastatin 80mg was found to be statistically significant in reducing the risk of such events compared to the placebo group (HR0.78, P=0.0002).*

FDA Label Image

Structure (Atorvastatin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.